Literature DB >> 15629463

Modulation of human dUTPase using small interfering RNA.

A W Studebaker1, W P Lafuse, R Kloesel, M V Williams.   

Abstract

Deoxyuridine triphosphate nucleotidohydrolase (dUTPase) is responsible for maintaining low intracellular levels of dUTP, thus preventing the incorporation of dUTP into DNA. A 21 bp double-stranded RNA molecule (siRNAdUT3) targeted against motif 3 of human dUTPase resulted in a time- and dose-dependent decrease in dUTPase activity in transfected cells. dUTPase activity was reduced approximately 95+/-5% in all cell lines tested 48 h after transfection with 2 microg siRNAdUT3 and it was maintained at this decreased level for at least 72 h. Down-regulation of dUTPase resulted in a significant increase in intracellular dUTP and a decreased proliferation of the transfected cells. Therefore, we conclude that dUTPase activity/expression can be down-regulated using siRNA specifically targeted to dUTPase mRNA and that this approach can be used to elucidate the role of dUTPase in DNA metabolism, as well as, to determine whether dUTPase is a valid target for drug development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629463     DOI: 10.1016/j.bbrc.2004.12.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Highly potent dUTPase inhibition by a bacterial repressor protein reveals a novel mechanism for gene expression control.

Authors:  Judit E Szabó; Veronika Németh; Veronika Papp-Kádár; Kinga Nyíri; Ibolya Leveles; Abris Á Bendes; Imre Zagyva; Gergely Róna; Hajnalka L Pálinkás; Balázs Besztercei; Olivér Ozohanics; Károly Vékey; Károly Liliom; Judit Tóth; Beáta G Vértessy
Journal:  Nucleic Acids Res       Date:  2014-10-01       Impact factor: 16.971

Review 2.  Deoxyuracil in DNA and disease: Genomic signal or managed situation?

Authors:  James Chon; Martha S Field; Patrick J Stover
Journal:  DNA Repair (Amst)       Date:  2019-02-27

3.  Proteomic analysis of human brain microvascular endothelial cells reveals differential protein expression in response to enterovirus 71 infection.

Authors:  Wenying Luo; Jiayu Zhong; Wei Zhao; Jianjun Liu; Renli Zhang; Liang Peng; Wenxu Hong; Sheng He Huang; Hong Cao
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

4.  Structural model of human dUTPase in complex with a novel proteinaceous inhibitor.

Authors:  Kinga Nyíri; Haydyn D T Mertens; Borbála Tihanyi; Gergely N Nagy; Bianka Kőhegyi; Judit Matejka; Matthew J Harris; Judit E Szabó; Veronika Papp-Kádár; Veronika Németh-Pongrácz; Olivér Ozohanics; Károly Vékey; Dmitri I Svergun; Antoni J Borysik; Beáta G Vértessy
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

5.  CRISPR/Cas9-Mediated Knock-Out of dUTPase in Mice Leads to Early Embryonic Lethality.

Authors:  Hajnalka Laura Pálinkás; Gergely Attila Rácz; Zoltán Gál; Orsolya Ivett Hoffmann; Gergely Tihanyi; Gergely Róna; Elen Gócza; László Hiripi; Beáta G Vértessy
Journal:  Biomolecules       Date:  2019-04-04

6.  Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage.

Authors:  Peter M Wilson; William Fazzone; Melissa J LaBonte; Heinz-Josef Lenz; Robert D Ladner
Journal:  Nucleic Acids Res       Date:  2008-11-16       Impact factor: 16.971

Review 7.  Deoxyuracil in DNA in health and disease.

Authors:  Joydeep Chakraborty; Patrick J Stover
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2020-07       Impact factor: 3.620

8.  Trading in cooperativity for specificity to maintain uracil-free DNA.

Authors:  Judit E Szabó; Enikő Takács; Gábor Merényi; Beáta G Vértessy; Judit Tóth
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

9.  Differential control of dNTP biosynthesis and genome integrity maintenance by the dUTPase superfamily enzymes.

Authors:  Rita Hirmondo; Anna Lopata; Eva Viola Suranyi; Beata G Vertessy; Judit Toth
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.